Stack of folded newspapers on a wooden table with a focus on printed pages.

The prodromal phase in Myalgic Encephalomyelitis (ME)

The prodromal phase in Myalgic Encephalomyelitis (ME), as described in the International Consensus Criteria (ICC) context, refers to the early period before the illness becomes fully established, when initial symptoms begin to appear but may not yet meet full diagnostic criteria.

In ME, this phase is often triggered by an infection or other physiological stressor (commonly viral, such as EBV), and can include symptoms like profound fatigue, flu-like malaise, sore throat, lymph node tenderness, cognitive fog, sleep disruption, and autonomic changes. What distinguishes the prodromal stage in ME is that it’s not just a typical recovery period—it reflects the early breakdown of homeostasis, where immune, neurological, and metabolic systems begin to dysregulate.

Within the ICC framework, the prodromal period is important because it can mark the transition into a chronic, neuroimmune disease state. Early signs of post-exertional neuroimmune exhaustion (PENE) may begin to appear, even if subtly, and the body’s ability to recover from exertion becomes impaired. In some cases, what looks like a prolonged “post-viral” illness is actually this prodromal stage evolving into established ME.

Not everyone experiences a clearly defined prodrome, but when present, it can last weeks to months before the illness stabilizes into its more persistent pattern.

…..

These terms get mixed together a lot, but in ME (especially under the ICC), they describe different points and patterns in the illness:

Prodromal phase (early onset period)

This is the lead-in to the illness. It usually follows an infection or major stressor and looks like a prolonged “not recovering properly” phase. Symptoms are building—fatigue, flu-like feelings, cognitive issues, sleep disruption – but may not yet meet full ME criteria. The key feature is progression: the body is losing its ability to return to baseline, and early signs of post-exertional worsening may start to show.

Established ME (meeting ICC criteria)

This is when the illness has fully declared itself, with hallmark features like post-exertional neuroimmune exhaustion (PENE), neurological impairment, immune dysfunction, and energy metabolism issues. Symptoms are more consistent and reproducible, especially the abnormal response to exertion.

Relapse (or “crash”)

A relapse happens after ME is established. It’s a worsening of symptoms triggered by exertion or stress – physical, cognitive, or sensory. The defining feature is that even small efforts can lead to a disproportionate, delayed, and prolonged symptom flare. Unlike the prodromal phase, a relapse is not the start of the illness – it’s a flare within it.

Remission

Remission means symptoms improve significantly, sometimes to the point where a person can function relatively well. However, the underlying vulnerability usually remains. People in remission can still relapse if they exceed their energy limits, so it’s not considered a full cure.

Post-viral fatigue (PVF)

This is often confused with early ME. PVF is a temporary recovery phase after an infection, where fatigue and weakness linger but gradually improve over time. The key difference is that PVF does not involve the persistent, pathological post-exertional response (PENE) seen in ME, and people steadily return to baseline rather than deteriorating or plateauing.

In short:

* Prodromal = onset and progression toward ME

* ME (ICC) = established, multi-system disease with PENE

* Relapse = flare within the illness

* Remission = partial or temporary improvement

* Post-viral fatigue = gradual recovery, not chronic dysfunction

References

https://pmc.ncbi.nlm.nih.gov/articles/PMC8201170/….

https://pmc.ncbi.nlm.nih.gov/articles/PMC7431524/….

www.mesocietyedmonton.org.

https://www.cdc.gov/…/hcp/clinical-overview/index.html….

https://pmc.ncbi.nlm.nih.gov/articles/PMC8835111/…(0–4%20Months,body%20(42–45).

https://me-pedia.org/wiki/Myalgic_encephalomyelitis….

https://www.frontiersin.org/…/10…/fneur.2020.00826/full

https://cdn.clinicaltrials.gov/…/NCT02…/Prot_SAP_000.pdf

https://www.researchgate.net/…/352195539_Warning…

#NightingaleContinuum

#GAMEICC

Similar Posts